Brief: Cytomed Therapeutics Limited Announces Pricing Of Initial Public Offering
April 13 (Reuters) - Cytomed Therapeutics Ltd GDTC.O :
* CYTOMED THERAPEUTICS LIMITED ANNOUNCES PRICING OF INITIAL
PUBLIC
OFFERING
* PRICING OF ITS INITIAL PUBLIC OFFERING OF ITS 2.4 MILLION
ORDINARY SHARES AT A PRICE OF US$4.00 PER SHARE
Source text for Eikon: ID:nPn4LKGpGa
Further company coverage: GDTC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CytoMed Therapeutics
See all newsBrief: Cytomed Therapeutics Limited Announces Receipt Of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Brief: Cytomed Therapeutics Refutes "Misleading" Claims & Reaffirms Clinical Progress
Brief: Cytomed Therapeutics Completes Acquisition Of T Cell Technology From Uk To Treat Cancers In China And India
Brief: CytoMed Therapeutics To Start Dose Level 2 In Angelica Trial Q3 2025
Brief: Cytomed Therapeutics Ltd Files For Mixed Shelf Of Up To $50 Million